Cubist Systematic Strategies, LLC Medtronic PLC Call Options Transaction History

Cubist Systematic Strategies, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$76.84 - $91.03 $3.6 Million - $4.26 Million	-46,800 Reduced 89.14%	5,700 $513,000
Q2 2024 Aug 14, 2024	SELL	$78.71 - $87.02 $9.89 Million - $10.9 Million	-125,600 Reduced 70.52%	52,500 $4.13 Million
Q1 2024 May 15, 2024	BUY	$82.84 - $88.09 $1.11 Million - $1.18 Million	13,400 Added 8.14%	178,100 $15.5 Million
Q4 2023 Feb 14, 2024	BUY	$69.43 - $83.43 $4.78 Million - $5.75 Million	68,900 Added 71.92%	164,700 $13.6 Million
Q3 2023 Nov 14, 2023	BUY	$78.22 - $90.4 $2.88 Million - $3.33 Million	36,800 Added 62.37%	95,800 $7.51 Million
Q2 2023 Aug 14, 2023	SELL	$79.47 - $91.38 $7.86 Million - $9.04 Million	-98,900 Reduced 62.63%	59,000 $5.2 Million
Q1 2023 May 15, 2023	SELL	$76.72 - $87.58 $2.31 Million - $2.64 Million	-30,100 Reduced 16.01%	157,900 $12.7 Million
Q4 2022 Feb 14, 2023	BUY	$76.18 - $87.74 $2.84 Million - $3.27 Million	37,300 Added 24.75%	188,000 $14.6 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $11.1 Million - $13.1 Million	137,600 Added 1050.38%	150,700 $12.2 Million
Q2 2022 Aug 15, 2022	BUY	$87.4 - $113.09 $1.14 Million - $1.48 Million	13,100 New	13,100 $1.18 Million

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.